Banerji, MA, Buckley, MC, Chaiken, RL, Gordon, D, Lebovitz, HE & Kral, JG (1995) Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. International Journal of Obesity 19, 846–850.
Björntorp, P (1994) Fatty acids, hyperinsulinemia, and insulin resistance: which comes first? Current Opinion in Lipidology 5, 166–174.
Björntorp, P (1995) Liver triglycerides and metabolism. International Journal of Obesity 19, 839–840.
Blaak, EE, Van Baak, MA, Kemerink, GJ, Pakbiers, MT, Heidendal, GA & Saris, WH (1994) β-adrenergicstimulation of energy expenditure and forearm skeletal muscle metabolism in lean and obese men. American Journal of Physiology 267, E306–E315.
Boden, G, Chen, X, Ruiz, J, White, JV & Rossetti, L (1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. Journal of Clinical Investigation 93, 2438–2446.
Bogardus, C, Lillioja, S, Mott, DM, Hollenbeck, C & Reaven, G (1985) Relationship between degree of obesity and in vivo insulin action in man. American Journal of Physiology 248, E286–E291.
Brunzell, JD & Hokanson, JE (1999) Dyslipidemia of central obesity and insulin resistance. Diabetes Care 22, Suppl. 3, C10–C13.
Campbell, PJ, Carlson, MG & Nurjhan, N (1994) Fat metabolism in human obesity. American Journal of Physiology 266, E600–E605.
Cao, H & Hegele, RA (2000) Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Human and Molecular Genetics 9, 109–112.
Carpentier, A, Mittelman, SD, Lamarche, B, Bergman, RN, Giacca, A & Lewis, GF (1999) Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. American Journal of Physiology 276, E1055–E1066.
Clausen, JO, Borch-Johnsen, K, Ibsen, H, Bergman, RN, Hougaard, P, Winther, K & Pedersen, O (1996) Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. Journal of Clinical Investigation 98, 1195–1209.
Colberg, SR, Simoneau, J-A, Thaete, FL & Kelley, DE (1995) Skeletal muscle utilization of free fatty acids in women with visceral obesity. Journal of Clinical Investigation 95, 1846–1853.
Considine, RV, Sinha, MK, Heiman, ML, Kriauciunas, A, Stephens, TW, Nyce, MR, Ohannesian, JP, Marco, CC, McKee, LJ, Bauer, TL & Caro, JF (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New England Journal of Medicine 334, 292–295.
Coppack, SW, Evans, RD, Fisher, RM, Frayn, KN, Gibbons, GF, Humphreys, SM, Kirk, MJ, Potts, JL & Hockaday, TDR (1992) Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism 41, 264–272.
Coppack, SW, Fisher, RM, Gibbons, GF, Humphreys, SM, McDonough, MJ, Potts, JL & Frayn, KN (1990) Postprandial substrate deposition in human forearm and adipose tissues in vivo. Clinical Science 79, 339–348.
Eckel, RH (1987) Adipose tissue lipoprotein lipase. In Lipoprotein Lipase, pp. 79–132 [Borensztajn, J, editor]. Chicago, IL: Evener.
Eckel, RH (1992) Insulin resistance: an adaptation for weight maintenance. Lancet 340, 1452–1453.
Ellis, BA, Poynten, A, Lowy, AJ, Furler, SM, Chisholm, DJ, Kraegen, EW & Cooney, GJ (2000) Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. American Journal of Physiology 279, E554–E560.
Farese, RV, Yost, TJ & Eckel, RH (1991) Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans. Metabolism 40, 214–216.
Ferrannini, E, Barrett, EJ, Bevilacqua, S & DeFronzo, RA (1983) Effect of fatty acids on glucose production and utilization in man. Journal of Clinical Investigation 72, 1737–1747.
Flatt, J-P (1972) Role of the increased adipose tissue mass in the apparent insulin insensitivity of obesity. American Journal of Clinical Nutrition 25, 1189–1192.
Flatt, JP (1988) Importance of nutrient balance in body weight regulation. Diabetes/Metabolism Reviews 4, 571–581.
Forouhi, NG, Jenkinson, G, Thomas, EL, Mullick, S, Mierisova, S, Bhonsle, U, McKeigue, PM & Bell, JD (1999) Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men. Diabetologia 42, 932–935.
Frayn, KN (1993) Insulin resistance and lipid metabolism. Current Opinion in Lipidology 4, 197–204.
Frayn, KN, Coppack, SW, Humphreys, SM, Fisher, RM & Allman, RFC (1991) Adipose tissue insulin resistance in obesity: protective mechanism or risk factor for heart disease? International Journal of Obesity 15, Suppl. 1, 55 Abstr.
Ganda, OP (2000) Lipoatrophy, lipodystrophy, and insulin resistance. Annals of Internal Medicine 133, 304–306.
Gavrilova, O, Marcus Samuels, B, Graham, D, Kim, JK, Shulman, GI, Castle, AL, Vinson, C, Eckhaus, M & Reitman, ML (2000) Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. Journal of Clinical Investigation 105, 271–278.
Goto, T, Onuma, T, Takebe, K & Kral, JG (1995) The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. International Journal of Obesity 19, 841–845.
Grill, V & Qvigstad, E (2000) Fatty acids and insulin secretion. British Journal of Nutrition 83, Suppl. 1, S79–S84.
Hauner, H, Bender, M, Haastert, B & Hube, F (1998) Plasma concentrations of soluble TNF-alpha receptors in obese subjects. International Journal of Obesity 22, 1239–1243.
Himsworth, HP (1936) Diabetes mellitus. Its differentiation into insulin-sensitive and insulin-insensitive types. Lancet i, 127–130.
Hofmann, C, Lorenz, K, Braithwaite, SS, Colca, JR, Palazuk, BJ, Hotamisligil, GS & Spiegelman, BM (1994) Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134, 264–270.
Hotamisligil, GS & Spiegelman, BM (1994) Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43, 1271–1278.
Insel, PA, Liljenquist, JE, Tobin, JD, Sherwin, RS, Watkins, P, Andres, R & Berman, M (1975) Insulin control of glucose metabolism in man. A new kinetic analysis. Journal of Clinical Investigation 55, 1057–1066.
Jeppesen, J, Hollenbeck, CB, Zhou, M-Y, Coulston, AM, Jones, C, Chen, Y-DI, & Reaven, GM (1995) Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia. Arteriosclerosis, Thrombosis and Vascular Biology 15, 320–324.
Kalant, D, Phélis, S, Fielding, BA, Frayn, KN, Cianflone, K & Sniderman, AD (2001) Increased postprandial fatty acid trapping in subcutaneous adipose tissue in obese women. Journal of Lipid Research 41, 1963–1968.
Kaplan, NM (1989) The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Archives of Internal Medicine 149, 1514–1520.
Karam, JH, Grodsky, GM & Forsham, PH (1963) Excessive insulin response to glucose in obese subjects as measured by immunochemical assay. Diabetes 12, 197–204.
Kim, JK, Gavrilova, O, Chen, Y, Reitman, ML & Shulman, GI (2000) Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. Journal of Biological Chemistry 275, 8456–8460.
Koistinen, HA, Bastard, JP, Dusserre, E, Ebeling, P, Zegari, N, Andreelli, F, Jardel, C, Donner, M, Meyer, L, Moulin, P, Hainque, B, Riou, JP, Laville, M, Koivisto, VA & Vidal, H (2000) Subcutaneous adipose tissue expression of tumour necrosis factor-a is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects. European Journal of Clinical Investigation 30, 302–310.
Koyama, K, Chen, G, Lee, Y & Unger, RH (1997) Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. American Journal of Physiology 273, E708–E713.
Landin, K, Stigendal, L, Eriksson, E, Krotkiewski, M, Risberg, B, Tengborn, L & Smith, U (1990) Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 39, 1044–1048.
Lewis, GFO, Meara, NM, Soltys, PA, Blackman, JD, Iverius, PH, Druetzler, AF, Getz, GS & Polonsky, KS (1990) Postprandial lipoprotein metabolism in normal and obese subjects: comparison after the vitamin A fat-loading test. Journal of Clinical Endocrinology and Metabolism 71, 1041–1050.
Lind, L, Fugmann, A, Branth, S, Vessby, B, Millgård, J, Berne, C & Lithell, H (2000) The impairment in endothelial function induced by non-esterified fatty acids can be reversed by insulin. Clinical Science 99, 169–174.
Miesenböck, G & Patsch, JR (1992) Postprandial hyperlipidemia: the search for the atherogenic lipoprotein. Current Opinion in Lipidology 3, 196–201.
Mohamed-Ali, V, Goodrick, S, Rawesh, A, Katz, DR, Miles, JM, Yudkin, JS, Klein, S & Coppack, SW (1997) Subcutaneous adipose tissue secretes interleukin-6 but not tumor necrosis factor-a in vivo. Journal of Clinical Endocrinology and Metabolism 82, 4196–4200.
Mohamed-Ali, V, Pinkney, JH & Coppack, SW (1998) Adipose tissue as an endocrine and paracrine organ. International Journal of Obesity 22, 1145–1158.
Ong, JM & Kern, PA (1989) Effect of feeding and obesity on lipoprotein lipase activity, immunoreactive protein, and messenger RNA levels in human adipose tissue. Journal of Clinical Investigation 84, 305–311.
Opie, LH & Walfish, PG (1963) Plasma free fatty acid concentrations in obesity. New England Journal of Medicine 268, 757–760.
Patsch, JR, Prasad, S, Gotto, AMJ & Bengtsson-Olivecrona, G (1984) Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase. Journal of Clinical Investigation 74, 2017–2023.
Phillips, DIW, Caddy, S, Ilic, V, Fielding, BA, Frayn, KN, Borthwick, AC & Taylor, R (1996) Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in non-diabetic subjects. Metabolism 45, 947–950.
Rabinowitz, D & Zierler, KL (1961) Forearm metabolism in obesity and its response to intra-arterial insulin. Evidence for adaptive hyperinsulinism. Lancet i, 690–692.
Randle, PJ, Garland, PB, Hales, CN & Newsholme, EA (1963) The glucose-fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet i, 785–789.
Reaven, GM (1988) Role of insulin resistance in human disease. Diabetes 37, 1595–1607.
Sadur, CN & Eckel, RH (1982) Insulin stimulation of adipose tissue lipoprotein lipase. Use of the euglycemic clamp technique. Journal of Clinical Investigation 69, 1119–1125.
Saghizadeh, M, Ong, JM, Garvey, WT, Henry, RR & Kern, PA (1996) The expression of TNFa by human muscle. Relationship to insulin resistance. Journal of Clinical Investigation 97, 1111–1116.
Shackleton, S, Lloyd, DJ, Jackson, SN, Evans, R, Niermeijer, MF, Singh, BM, Schmidt, H, Brabant, G, Kumar, S, Durrington, PN, Gregory, S, O'Rahilly, S & Trembath, RC (2000) LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nature Genetics 24, 153–156.
Shimabukuro, M, Koyama, K, Chen, G, Wang, M-Y, Trieu, F, Lee, Y, Newgard, CB & Unger, RH (1997) Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proceedings of the National Academy of Sciences, USA 94, 4637–4641.
Sniderman, AD, Cianflone, K, Summers, LKM, Fielding, BA & Frayn, KN (1997) The acylation-stimulating protein pathway and regulation of postprandial metabolism. Proceedings of the Nutrition Society 56, 703–712.
Spiegelman, BM & Flier, JS (1996) Adipogenesis and obesity: rounding out the big picture. Cell 87, 377–389.
Steinberg, HO, Paradisi, G, Hook, G, Crowder, K, Cronin, J & Baron, AD (2000) Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes 49, 1231–1238.
Steinberg, HO, Tarshoby, M, Monestel, R, Hook, G, Cronin, J, Johnson, A, Bayazeed, B & Baron, AD (1997) Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. Journal of Clinical Investigation 100, 1230–1239.
Tooke, JE & Hannemann, MM (2000) Adverse endothelial function and the insulin resistance syndrome. Journal of Internal Medicine 247, 425–431.
Unger, RH (1995) Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44, 863–870.